Understanding Certificates of Analysis in Peptide Research
A guide to reading and interpreting COA documentation, including HPLC purity, mass spectrometry identity, endotoxin screening, and net peptide content results.
What Is a Certificate of Analysis?
A Certificate of Analysis (COA) is an official document issued by a testing laboratory that reports the analytical test results for a specific production batch of a research compound. COAs serve as the primary quality verification record, providing researchers with traceable evidence that a compound meets defined specifications for identity, purity, and safety parameters.
For peptide research, COAs are essential documentation that supports experimental reproducibility. Without verified analytical data, researchers cannot confirm that their experimental results are attributable to the intended compound at the expected purity level rather than to synthesis impurities, degradation products, or misidentified materials.
HPLC Purity Results
The HPLC purity result is typically the first value researchers check on a COA. Reported as a percentage (e.g., 99.2%), this number represents the proportion of the target peptide relative to all detected species in the chromatographic separation. Higher purity indicates fewer synthesis impurities and degradation products.
When interpreting HPLC purity, note the specific method conditions: column type (C18 vs C8), gradient program, detection wavelength (typically 214 nm or 220 nm for peptides), and whether the result represents area percent or weight percent. Different analytical conditions can produce slightly different purity values for the same sample, so consistency in method is important for batch-to-batch comparisons.
Mass Spectrometry Identity
The mass spectrometry result confirms molecular identity by reporting the observed molecular weight and comparing it to the theoretical (calculated) molecular weight. The COA typically reports the observed [M+H]+ ion (protonated molecular ion) or multiply-charged species along with the theoretical value and the deviation.
A match within ±1 Da on unit-resolution instruments (or ±0.01 Da on high-resolution instruments) confirms correct molecular identity. If the observed mass differs from the theoretical mass by more than the instrument specification, the compound may have an incorrect sequence, unexpected modification, or may not be the intended product.
Endotoxin Screening
Endotoxin (lipopolysaccharide, LPS) contamination from gram-negative bacteria is a critical quality parameter for research peptides. The Limulus Amebocyte Lysate (LAL) assay quantifies endotoxin levels in Endotoxin Units per milligram (EU/mg). Research-grade peptides should have endotoxin levels below established thresholds, typically <1 EU/mg.
Elevated endotoxin levels can confound research results by activating innate immune signaling pathways (TLR4, NF-kB) that are unrelated to the peptide's intended signaling activity. This is particularly important for cell-based assays involving immune cells, where endotoxin contamination can produce false-positive pathway activation.
Net Peptide Content
Net peptide content (NPC) reports the percentage of active peptide in the lyophilized material by weight. A vial labeled as containing 10 mg of peptide with 80% NPC contains 8 mg of actual peptide and 2 mg of counter-ions (typically trifluoroacetate or acetate salts), moisture, and other non-peptide components.
NPC is critical for preparing accurate molar concentrations. Researchers calculating molarity from the label weight without adjusting for NPC will overestimate the actual peptide concentration, potentially affecting dose-response curves and experimental reproducibility. Always use the NPC-adjusted weight for concentration calculations.
Batch Traceability & Third-Party Testing
Every COA should include a unique batch or lot number that links the analytical results to a specific production run. This traceability allows researchers to reference the exact COA for their specific material and enables batch-specific quality investigations if experimental anomalies arise. At Instant Peptides, every batch undergoes seven rounds of independent testing through certified third-party laboratories. Full COA documentation is publicly available through our Batch Verification Tool.
Research Use Only. All products sold by Instant Peptides are supplied solely for laboratory and research use. They are not intended for human or animal consumption, clinical use, diagnostic use, or therapeutic application. Statements have not been evaluated by the FDA.